GB0911892D0 - Parathyroid hormone related protein antagonists - Google Patents

Parathyroid hormone related protein antagonists

Info

Publication number
GB0911892D0
GB0911892D0 GBGB0911892.8A GB0911892A GB0911892D0 GB 0911892 D0 GB0911892 D0 GB 0911892D0 GB 0911892 A GB0911892 A GB 0911892A GB 0911892 D0 GB0911892 D0 GB 0911892D0
Authority
GB
United Kingdom
Prior art keywords
related protein
parathyroid hormone
hormone related
protein antagonists
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0911892.8A
Other versions
GB2471693A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Complix NV
Original Assignee
Complix NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Complix NV filed Critical Complix NV
Priority to GB0911892A priority Critical patent/GB2471693A/en
Publication of GB0911892D0 publication Critical patent/GB0911892D0/en
Priority to PCT/EP2010/059713 priority patent/WO2011003935A1/en
Publication of GB2471693A publication Critical patent/GB2471693A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0911892A 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists Withdrawn GB2471693A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0911892A GB2471693A (en) 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists
PCT/EP2010/059713 WO2011003935A1 (en) 2009-07-08 2010-07-07 Parathyroid hormone related protein antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0911892A GB2471693A (en) 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists

Publications (2)

Publication Number Publication Date
GB0911892D0 true GB0911892D0 (en) 2009-08-19
GB2471693A GB2471693A (en) 2011-01-12

Family

ID=41022368

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0911892A Withdrawn GB2471693A (en) 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists

Country Status (2)

Country Link
GB (1) GB2471693A (en)
WO (1) WO2011003935A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015504064A (en) * 2012-01-06 2015-02-05 コンプリクス エン ヴェー Binding agents for intracellular target molecules
AU2013336753B2 (en) 2012-10-22 2018-02-01 Complix Nv Polypeptides capable of cellular internalization
CN105431548A (en) 2013-03-15 2016-03-23 生物医学研究机构基金会 Method for the diagnosis, prognosis and treatment of cancer metastasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990035755A (en) * 1995-07-20 1999-05-25 와트 씨 데이빗, 해리 에이 루스제 Compounds related to parathyroid hormone-like proteins and methods for their preparation
ATE420661T1 (en) * 2000-04-28 2009-01-15 Chugai Pharmaceutical Co Ltd CELL PROLIFERATION INHIBITORS
WO2005077103A2 (en) * 2004-02-12 2005-08-25 Regents Of The University Of Colorado Compositions and methods for modification and prevention of sars coronavirus infectivity
US9217011B2 (en) * 2007-09-07 2015-12-22 Complix Nv Non-natural proteinaceous scaffold made of three non-covalently associated peptides

Also Published As

Publication number Publication date
WO2011003935A4 (en) 2011-04-07
GB2471693A (en) 2011-01-12
WO2011003935A1 (en) 2011-01-13
WO2011003935A9 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
HRP20191852T8 (en) Polypeptides
HK1218558A1 (en) Mirac proteins mirac
HK1209761A1 (en) Polypeptides
EP2555797A4 (en) Tnf- binding proteins
EP2649189A4 (en) Tnf- binding proteins
ZA201202266B (en) Insecticidal proteins
EP2480578A4 (en) Polypeptide modification
GB0916749D0 (en) Peptide cleaning agents
EP2751136A4 (en) Natriuretic polypeptides
IL222000A0 (en) Arylsulfonamide ccr3 antagonists
HK1176927A1 (en) Arylsulfonamide ccr3 antagonists ccr3
EP2478001A4 (en) Advantageous mu-opiate receptor peptide compounds
GB201016494D0 (en) Polypeptide
ZA201109283B (en) Protein
EP2435468A4 (en) Fibromodulin peptide
HK1173358A1 (en) Fviii-derived peptides fviii
GB0911892D0 (en) Parathyroid hormone related protein antagonists
ZA201203722B (en) Peptide
EP2614076A4 (en) Modified relaxin polypeptides
GB0917685D0 (en) Antigenic polypeptide
EP2439209A4 (en) Endokinin c/d-origin peptides
TWI370607B (en) Vibrator
GB0910481D0 (en) Hormone fusion polypeptides
GB0909384D0 (en) Protein
IL214496A0 (en) Short b-defensin-derived peptides

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)